Cancer Controls Related Specimens
178 Cancer Controls Patients
Note: The majority of patients have donated multiple samples.
122 with serum
162 with DNA
On the REPROCELL blog
Latest in Drug Discovery
Key Strategies Central Labs Use to Fast-Track Time to Market
Learn how central labs use automation, outsourcing, and AI to accelerate drug development, reduce costs, and improve clinical trial accuracy and efficiency.
21 May 2025
How Biomarkers Are Shaping the Future of Skin Disease Treatment
Discover how biomarkers are revolutionizing the treatment of skin diseases by enabling more precise and effective therapies.
04 February 2025
Redefining Success in IBD Drug Discovery with Human Tissue Models
Redefining IBD drug discovery with a dual-pronged approach through human bioengineered and fresh tissue.
11 December 2024
REPROCELL's Advanced Skin Tissue Engineering
Discover REPROCELL's pioneering 3D skin tissue engineering, enhancing drug development and skincare research with accurate and robust human skin models.
31 October 2024